Capecitabine Dosing Calculator
Your Dosage
Body Surface Area (BSA): m²
Daily Dose: mg
Per Dose (Morning/Evening): mg
Important Instructions
Take with water within 30 minutes after a light meal. Swallow tablets whole.
When doctors prescribe Capecitabine an oral prodrug of 5‑fluorouracil used in several solid tumors, patients often wonder how it differs from traditional IV chemotherapy. This guide walks through everything you need to know - from how the drug works to practical tips for managing side effects.
What Is Capecitabine?
Capecitabine is sold under the brand name Xeloda. It belongs to the class of fluoropyrimidines, a family of drugs that interfere with DNA synthesis in rapidly dividing cells. Unlike its intravenous counterpart 5‑fluorouracil, capecitabine is taken by mouth, making it a convenient option for many patients.
How It Works - The Prodrug Pathway
Capecitabine itself is inactive until it reaches the tumor. Inside the body, three enzymatic steps convert it to the active metabolite 5‑fluorouracil (5‑Fluorouracil, or 5‑FU). The final step is catalyzed by Thymidine Phosphorylase, an enzyme that is often higher in tumor tissue than in normal tissue. This selective activation helps concentrate the drug where it’s needed most, while sparing some healthy cells.
Approved Cancer Indications
Regulatory agencies have cleared capecitabine for several solid‑tumor settings:
- Adjuvant treatment of stage III Colon Cancer after surgery.
- Metastatic Breast Cancer, either alone or in combination with targeted agents.
- Advanced gastric and gastro‑esophageal junction cancers.
- Head and neck squamous cell carcinoma in combination with radiation.
Off‑label use is also common for pancreatic and pancreatic‑biliary cancers, but those decisions should involve a specialist.
Dosing and Administration Guidelines
Capecitabine is usually taken twice daily for 14 days followed by a 7‑day rest period, completing a 21‑day cycle. The basic dose is 1250mg/m² per day, split into two equal doses. Adjustments are required for renal impairment, age, or body surface area extremes.
- Calculate body surface area (BSA) using the Mosteller formula.
- Multiply BSA by the standard dose (1250mg/m²) to get the total daily dose.
- Divide the total daily dose by two - that’s the amount to take each morning and evening.
- For patients with creatinine clearance < 30mL/min, reduce the dose by 50%.
- Monitor blood counts and liver function before each cycle.
Because the drug is taken orally, timing with meals matters: swallow each dose with water within 30minutes after a light meal to improve absorption.
Common Side Effects and Management
The most distinctive toxicity is Hand‑Foot Syndrome (palmar‑plantar erythrodysesthesia). Symptoms range from tingling to painful blistering on the palms and soles. Early strategies include:
- Cooling the hands and feet with cool water soaks.
- Using urea‑based moisturizers to keep skin supple.
- Reducing the dose by 25% at the first sign of grade2 toxicity.
Other frequent adverse events are diarrhea, mucositis, and nausea. Maintaining hydration, using anti‑diarrheal agents (e.g., loperamide), and good oral hygiene can keep these under control. Importantly, a deficiency in Dihydropyrimidine Dehydrogenase (DPD) can cause severe, life‑threatening toxicity. Screening for DPD activity before starting therapy is increasingly recommended.
Interactions, Contra‑Indications, and Precautions
Capecitabine should not be combined with other agents that heavily rely on the DPD pathway, such as certain antifolates. Concomitant radiation therapy in the same region can exacerbate skin toxicity. Patients with known hypersensitivity to fluoropyrimidines, significant hepatic impairment, or uncontrolled infections should avoid the drug.
Pregnant or breastfeeding individuals must not use capecitabine because it can cause fetal harm. Effective contraception is required during treatment and for at least three months after the last dose.
Capecitabine vs. Intravenous 5‑FU: A Quick Comparison
| Aspect | Capecitabine (Oral) | 5‑Fluorouracil (IV) |
|---|---|---|
| Administration | Twice‑daily oral tablets | Continuous infusion or bolus injection |
| Convenience | Can be taken at home; no infusion center needed | Requires clinic visits or implanted pump |
| Typical Hand‑Foot Toxicity | Higher incidence (up to 30%) | Rare (<5%) |
| Overall Efficacy | Non‑inferior in most approved settings | Established benchmark |
| Cost (US, 2025) | ≈$3,500 per 3‑week cycle (generic) | ≈$2,200 per cycle (drug only) |
Both drugs share the same active metabolite, but the oral route can improve quality of life for many patients, provided side effects are managed well.
Practical Tips for Patients on Capecitabine
- Keep a medication diary - note the exact time you take each dose.
- Stay hydrated; aim for at least 2L of water daily.
- Report any new skin changes, especially on hands or feet, to your oncologist promptly.
- Do not skip meals before dosing; a light snack enhances absorption.
- Carry a copy of your prescription and dosing schedule when traveling.
Following these simple habits can reduce the risk of severe toxicity and keep treatment on track.
Frequently Asked Questions
Frequently Asked Questions
Can I take capecitabine with food?
Yes. The tablets should be swallowed with water within 30minutes after a light meal. A high‑fat meal can delay absorption, so avoid heavy foods right before dosing.
What is the risk of developing hand‑foot syndrome?
Up to 30% of patients experience grade1‑2 symptoms, and about 5‑10% develop severe (grade3) toxicity that may require dose reduction or interruption.
Should I get tested for DPD deficiency before starting?
Testing is increasingly considered best practice because DPD deficiency can lead to life‑threatening reactions. If testing is unavailable, clinicians often start at a reduced dose and monitor closely.
Is it safe to become pregnant while on capecitabine?
No. Capecitabine is teratogenic. Effective contraception must be used during treatment and for at least three months afterward.
How long does a typical treatment cycle last?
A standard cycle is 21days: 14days of dosing followed by a 7‑day rest. The number of cycles depends on the cancer type and response, ranging from 6 to 12 cycles in most protocols.
Armed with this information, patients and caregivers can navigate capecitabine therapy more confidently. Remember, the key to success is open communication with the oncology team and proactive management of side effects.
For anyone starting this oral chemotherapy, a single Capecitabine pill can mean a shift from frequent clinic trips to a more manageable home‑based routine-provided the plan is followed and side effects are caught early.
Releted Post
Caspian Fothergill
Hello, my name is Caspian Fothergill. I am a pharmaceutical expert with years of experience in the industry. My passion for understanding the intricacies of medication and their effects on various diseases has led me to write extensively on the subject. I strive to help people better understand their medications and how they work to improve overall health. Sharing my knowledge and expertise through writing allows me to make a positive impact on the lives of others.
Wow, this guide breaks down Capecitabine like a well‑organized cheat‑sheet, and I love how the dosing steps are laid out, step‑by‑step, making it super easy to follow!!! The bit about hand‑foot syndrome really hit home-so many patients just ignore those early signs, but this shows why monitoring is a must, and I’m all for spreading that awareness!!!